Construction by its very nature is dirty, dusty work. Adam Bell, MD of Building Projects (UK), explains how pharmaceutical companies can avoid both contamination and disruption when undertaking an expansion project.
Construction work within a pharmaceutical facility has long been a specific discipline, requiring the experience and expertise of specialist construction professionals. This includes the design and build of clean, aseptic and sterile facilities, HVAC and mechanical and electrical (M&E) services for cleanrooms, laboratories, manufacturing and packaging areas, in line with ISO 9001:2008.
Pharmaceutical companies have come under increasing pressure in recent years to reduce the cost of products while balancing ever-stricter compliance and ever-changing global regulations. These challenges create a need to expand existing pharmaceutical plants to facilitate increased production as well as improve R&D productivity. Any building work carried out to extend facilities has to be completed with zero contamination and zero disruption, allowing business to go on as usual.
Completing a major construction project in a live pharmaceutical production environment requires considerable planning and stringent health and safety practices to achieve both zero contamination and zero disruption. That is why Building Projects (UK) developed its own High Care Environment Charter that sets out its commitment to providing high care construction services of the highest quality to the strictest safety standards.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.
Subscribe now Already a subscriber? Sign in here.